TIM‐4 increases the proportion of CD4+CD25+FOXP3+ regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL‐6 secretion
Abstract Background Currently, creating more effector T cells and augmenting their functions is a focal point in pancreatic ductal adenocarcinoma (PDAC) treatment research. T cell immunoglobulin domain and mucin domain molecule 4 (TIM‐4), known for promoting cancer progression in various malignancie...
Saved in:
Main Authors: | Ziyao Wang, Zerong Xie, Yu Mou, Ruiman Geng, Chen Chen, Nengwen Ke |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70110 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The dynamics of CD4+ T cell proliferation and regulation
by: Mingran Zhang, et al.
Published: (2025-12-01) -
ESAT-6 protein suppresses allograft rejection by inducing CD4+Foxp3+ regulatory T cells through IκBα/cRel pathway
by: Xiaofei Huang, et al.
Published: (2025-01-01) -
CD4+CD25+调节性T细胞的体外扩增
Published: (2008-01-01) -
IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury
by: Liwu Zeng, et al.
Published: (2025-02-01) -
Inactivation of the TIM complex components leads to a decrease in the level of DNA import into Arabidopsis mitochondria
by: T. A. Tarasenko, et al.
Published: (2023-12-01)